Methods for treating nervous system pathophysiologies using glial growth factors
US6194377A · kind A · utility
0Cited by
5References
22Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 22, 1996 |
| Grant date | Feb 27, 2001 |
| Priority date | — |
| Expiry date | Oct 22, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are methods for treating pathophysiological conditions of the mammalian nervous system. The methods involve administering pharmaceutically effective amounts of recombinant polypeptides comprising epidermal growth factor-like domains encoded by the GGF/p185erbB2 ligand gene.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.